Prostate Cancer: Quality of Life and New Therapeutic Options for Metastatic Castration-Resistant Prostate Cancer

The European Medical Journal shared this video of Hilary Glen, PhD, talking about the clinical impact of emerging treatments like “abiraterone acetate and enzalutamide in post-chemotherapy and pre-chemotherapy settings, in patients with metastatic castration-resistant prostate cancer.”

Learn more about prostate cancer:

Tagged , , , .

Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Leave a Comment

Your email address will not be published. Required fields are marked *